Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

health-med spÓŁka z ograniczonĄ odpowiedzialnoŚciĄ spÓŁka komandyto, poland ul. walewska 8/5, 04-022 warsaw, mazowieckie +22 490 64 98 - tropicamide - ey.dro.sol (ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ) - 1% (w/v) - tropicamide 1g - tropicamide

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

health-med sp. z o.o. sp. j. (0000011324) ul. walewska 8/5, warsaw, mazowieckie, 04-022 - tropicamide - eye drops, solution - 10mg/ml - tropicamide (0001508754) 1g

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Αντινεοπλασματικοί παράγοντες - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

taw pharma (ireland) limited - υδροχλωρική κλοπιδογρέλη - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - Αντιθρομβωτικοί παράγοντες - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

3m health care limited - rivastigmine - Νόσου Αλτσχάιμερ - psychoanaleptics, , Αναστολέας Χολινεστεράσης - Συμπτωματική θεραπεία της ήπιας έως μέτριας μορφής άνοιας του alzheimer.

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ge healthcare a.e. Σωρού 8-10 Δημητσάνας & Καλτεζών, 151 25 151 25, Μαρούσι 210.8930600 - metaiodobenzylguanidine (131 i) chloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 9,25-18,5mbq/ml - metaiodobenzylguanidine (131 i) chloride 9,25mbq - iobenguane (131i)

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ge healthcare a.e. Σωρού 8-10 Δημητσάνας & Καλτεζών, 151 25 151 25, Μαρούσι 210.8930600 - metaiodobenzylguanidine (131 i) chloride - cs.inj.sol (ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΕΝΕΣΙΜΟΥ ΔΙΑΛΥΜΑΤΟΣ) - 370mbq/ml - metaiodobenzylguanidine (131 i) chloride 370mbq - iobenguane (131i)

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ge healthcare a.e. Σωρού 8-10 Δημητσάνας & Καλτεζών, 151 25 151 25, Μαρούσι 210.8930600 - sodium iodide (131 i) - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 0,333-3,7 mbq - sodium iodide (131 i) - sodium iodide (131i)

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

george petrou ltd (0000003030) 50 areos str., lefkosia, 2234 - retinol; pantothenic acid; riboflavin; nicotinamide; iron; magnesium; manganese; molybdenum; potassium sulfate; chromium; copper; zinc; calcium; iodine; phosphorus; selenium; ergocalciferol; ascorbic acid; pyridoxine hydrochloride; biotin; tocopherol; folic acid; thiamine hydrochloride; cyanocobalamin - capsule,hard - retinol (0000068268) 2500iu; pantothenic acid (0000079834) 4mg; riboflavin (0000083885) 1,6mg; nicotinamide (0000098920) 18mg; iron (0007439896) 12mg; magnesium (0007439954) 30mg; manganese (0007439965) 3mg; molybdenum (0007439987) 250ug; potassium sulfate (0007778805) 4mg; chromium (0007440473) 200ug; copper (0007440508) 2mg; zinc (0007440666) 15mg; calcium (0007440702) 108mg; iodine (0007553562) 140ug; phosphorus (0007723140) 83mg; selenium (0007782492) 50ug; ergocalciferol (0000050146) 400iu; ascorbic acid (0000050817) 60mg; pyridoxine hydrochloride (0000058560) 2mg; biotin (0000058855) 100ug; tocopherol (0000059029) 10mg; folic acid (0000059303) 400ug; thiamine hydrochloride (0000067038) 1,2mg; cyanocobalamin (0000068199) 3ug - multivit and other minerals, incl combinations

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

accord healthcare s.l.u (0000009808) moll de barcelona, edifici est s/n, planta 6 , barcelona , 08039 - aripiprazole - orodispersible tablet - 10mg - aripiprazole (8000002594) 10mg - aripiprazole